Viewing Study NCT02582203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-02-24 @ 12:13 AM
Study NCT ID: NCT02582203
Status: COMPLETED
Last Update Posted: 2016-11-01
First Post: 2015-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
Sponsor: Wayne State University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Skin Diseases, Infectious View
None Staphylococcal Skin Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ceftaroline fosamil View
None Vancomycin View
None Acute bacterial skin and skin structure infections View
None Methicillin-resistant S. aureus View